Compare FRMM & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FRMM | MDAI |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | 2 | 65 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.8M | 60.1M |
| IPO Year | 2017 | N/A |
| Metric | FRMM | MDAI |
|---|---|---|
| Price | $5.10 | $1.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $5.00 | $3.00 |
| AVG Volume (30 Days) | 296.3K | ★ 838.8K |
| Earning Date | 05-26-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $183.55 | N/A |
| Revenue Next Year | $166.48 | $23.50 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.76 | $1.18 |
| 52 Week High | $5.87 | $3.21 |
| Indicator | FRMM | MDAI |
|---|---|---|
| Relative Strength Index (RSI) | 55.08 | 39.24 |
| Support Level | $3.61 | $1.78 |
| Resistance Level | $5.37 | $1.99 |
| Average True Range (ATR) | 0.44 | 0.11 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 52.81 | 18.60 |
Forum Markets Inc is a financial technology company focused on developing infrastructure that supports the origination, financing, and distribution of RWAs through blockchain-enabled capital markets. The company's business approach is centered on integrating traditional financial asset markets with blockchain-based infrastructure to enable the tokenization of income-generating real-world assets such as consumer credit, equipment finance assets, and other contractual cash-flow streams. It utilizes blockchain infrastructure, including Ethereum and related Layer-2 scaling protocols, to support the issuance, management, and potential secondary trading of tokenized financial instruments.
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.